XML 57 R40.htm IDEA: XBRL DOCUMENT v3.8.0.1
Related Party Transactions (Details Narrative)
1 Months Ended 12 Months Ended
May 11, 2017
$ / shares
shares
Feb. 10, 2017
shares
Feb. 02, 2017
shares
Jan. 10, 2017
shares
Sep. 09, 2016
USD ($)
shares
Feb. 02, 2016
USD ($)
$ / shares
shares
Oct. 19, 2017
USD ($)
Oct. 16, 2017
USD ($)
$ / shares
shares
Jul. 21, 2017
USD ($)
$ / shares
shares
Jun. 28, 2017
USD ($)
$ / shares
shares
Sep. 25, 2014
USD ($)
Number
Dec. 31, 2017
USD ($)
$ / shares
shares
Dec. 31, 2016
USD ($)
$ / shares
Feb. 23, 2017
USD ($)
Feb. 17, 2017
shares
Common stock shares reserved under stock option plan                       102,582      
Accounts payable | $                       $ 61,333 $ 33,290    
Research and development expense | $                       574,091 309,503    
Charitable Grant Agreement [Member]                              
Donation to the University | $                     $ 75,000        
Donation periodic payment | $                     $ 9,375        
Number of installments | Number                     8        
Joseph Sierchio [Member] | Equity Option [Member]                              
Common stock shares reserved under stock option plan   70,000                          
Debt conversion converted instrument shares issued   38,642                          
Joseph Sierchio [Member] | Loan agreement [Member]                              
Convertible debt financing, Loan received | $                           $ 25,000  
Principal amount | $             $ 25,000                
Accrued interest | $             $ 1,149                
KCC [Member] | Series B Warrant [Member]                              
Exercise price | $ / shares           $ 0.46                  
Debt conversion converted instrument shares issued           2,173,913                  
Proceeds from issuance of common stock | $           $ 1,000,000                  
KCC [Member] | Loan agreement [Member]                              
Convertible debt financing, Loan received | $         $ 700,000                 $ 395,000  
Interest rate         7.00%                 7.00%  
Maturity date         Dec. 31, 2019                    
KCC [Member] | Loan agreement [Member] | Series E Warrant [Member]                              
Common stock shares reserved under stock option plan         584,416                    
Kenneth Kirkland [Member] | Equity Option [Member]                              
Common stock shares reserved under stock option plan     40,000                        
Debt conversion converted instrument shares issued     29,642                        
StemCell Systems [Member]                              
Incurred expenses | $                       219,806 184,517    
Satterlee Stephens LLP [Member]                              
Accounts payable | $                       30,000 $ 11,750    
University of Pittsburgh [Member] | August 1, 2017 [Member]                              
Research and development expense | $                       171,595      
Joseph Sierchio [Member]                              
Annual retainer payable | $                       $ 6,000      
Common stock shares reserved under stock option plan 75,000                     50,000      
Exercise price | $ / shares $ 4.20                       $ 1.91    
Legal fees | $                       $ 277,933 $ 168,775    
Description for vested grant option

The 50,000 options became fully vested upon grant and the 75,000 options vested 50% on the date of grant and 50% one year hence.

                           
Joseph Sierchio [Member] | Series F [Member]                              
Common stock shares reserved under stock option plan                       7,246      
Joseph Sierchio [Member] | Private Placement [Member]                              
Common stock shares reserved under stock option plan               10,000              
Exercise price | $ / shares               $ 2.75              
Maturity date               Oct. 16, 2022              
Unit price per share | $ / shares               $ 2.50              
Proceeds from units reserved for future issuance | $               $ 25,000              
KCC [Member] | Series F Warrant [Member]                              
Exercise price | $ / shares                   $ 3.01          
Debt conversion converted instrument shares issued                   114,493          
Proceeds from issuance of common stock | $                   $ 344,624          
Number of warrants exercised shares                   114,493          
KCC [Member] | Series F [Member]                              
Common stock shares reserved under stock option plan                       114,493      
KCC [Member] | Private Placement [Member]                              
Common stock shares reserved under stock option plan                 410,000            
Exercise price | $ / shares                 $ 2.68            
Maturity date                 Jul. 21, 2022            
Unit price per share | $ / shares                 $ 2.44            
Proceeds from units reserved for future issuance | $                 $ 1,000,400            
Terms of agreement                

Each unit consisted of one share of common stock and one Series G Warrant to purchase one (1) share of common stock at an exercise price of $2.68 per share through July 21, 2022.

           
KCC [Member] | March 1, 2017 [Member]                              
Debt conversion converted instrument shares issued                       4,273,831      
KCC [Member] | March 1, 2017 [Member] | Series C Warrant [Member]                              
Number of warrants exercised shares                       3,092,637      
KCC [Member] | March 1, 2017 [Member] | Series B Warrant [Member]                              
Number of warrants exercised shares                       1,326,087      
Chief Financial Officer [Member] | Thomas bold [Member]                              
Common stock shares reserved under stock option plan                             40,000
Debt conversion converted instrument shares issued   34,296                          
Dr. Gerlach [Member]                              
Accounts payable | $                       $ 17,640 18,540    
Compensation expense for services | $                       38,540 42,480    
Dr. Gerlach [Member] | Series A [Member]                              
Common stock shares reserved under stock option plan       240,000                      
Debt conversion converted instrument shares issued       204,571                      
Mr. Bhogal [Member]                              
Compensation expense for services | $                       $ 81,600 $ 74,400    
Individual owning issue and outstanding share percent                       5.00%      
Kenneth Kirkland [Member]                              
Annual retainer payable | $                       $ 6,000      
Common stock shares reserved under stock option plan                       50,000      
Exercise price | $ / shares                       $ 1.91